<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40901519</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Research status and trends of drug-coated balloons in coronary artery disease: a bibliometric analysis.</ArticleTitle><Pagination><StartPage>1591906</StartPage><MedlinePgn>1591906</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1591906</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2025.1591906</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Drug-coated balloons have emerged as a pivotal alternative to drug-eluting stents in the interventional management of coronary artery disease, particularly showing clinical advantages in the treatment of in-stent restenosis and small-vessel disease. This study provides a systematic bibliometric analysis of publication trends, research hotspots, and future directions in DCB-related CAD research from 2004 to June 2025.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 1,092 publications indexed in the Web of Science, Scopus, and PubMed databases were analyzed using CiteSpace, VOSviewer, and bibliometrix. Inclusion criteria were English-language papers, while case reports, conference proceedings, news articles, and duplicate publications were excluded. The analysis focused on publication trends, country/institutional contributions, author collaboration networks, journal analysis, co-citation literature, and keyword evolution.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Three distinct developmental phases of DCB research were identified: (1) device optimization (2004-2010), (2) clinical validation (2010-2017), and (3) application to complex lesions (2018-present). China led in publication volume (<i>n</i> =&#x202f;180), while Germany and Italy demonstrated the highest research impact. Leading research institutions included Capital Medical University and Friedrich Schiller University of Jena. High-impact journals such as <i>JACC: Cardiovascular Interventions</i> and <i>EuroIntervention</i> served as key publication venues, with a focus on clinical outcomes and intravascular imaging. Keyword analysis revealed a growing emphasis on intravascular imaging modalities and emerging drug-coating technologies in recent research.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">DCB are now established as a standard of care for ISR (Class IA recommendation), with accumulating evidence supporting their efficacy and safety in small-vessel coronary disease. However, their application in complex lesions requires further validation through multicenter randomized controlled trials. Future research should focus on optimizing drug coating technologies, refining imaging-guided strategies, exploring new anti-proliferative drugs, and establishing more precise eligibility criteria for treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Yu, Jiao, Wang, Zhang and Yin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Yuemiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>L&#xfc;ya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Chengqian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bibliometric analysis</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">drug-coated balloon</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">research trends</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>18</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>18</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40901519</ArticleId><ArticleId IdType="pmc">PMC12399631</ArticleId><ArticleId IdType="doi">10.3389/fmed.2025.1591906</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. (2025) 149:e347. doi: 10.1161/CIR.0000000000001209</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001209</ArticleId><ArticleId IdType="pmc">PMC12146881</ArticleId><ArticleId IdType="pubmed">38264914</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. (2020) 76:2982&#x2013;3021. doi: 10.1016/j.jacc.2020.11.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, et al. Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group. JACC Cardiovasc Interv. (2020) 13:1391&#x2013;402. doi: 10.1016/j.jcin.2020.02.043, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2020.02.043</ArticleId><ArticleId IdType="pubmed">32473887</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. (2019) 14:1435&#x2013;534. doi: 10.4244/EIJY19M01_01, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJY19M01_01</ArticleId><ArticleId IdType="pubmed">30667361</ArticleId></ArticleIdList></Reference><Reference><Citation>Fezzi S, Giacoppo D, Fahrni G, Latib A, Alfonso F, Colombo A, et al. Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study. Eur Heart J. (2025) 46:1586&#x2013;99. doi: 10.1093/eurheartj/ehaf002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaf002</ArticleId><ArticleId IdType="pubmed">39981922</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaj A, Leone PP, Colombo A, Vinayak M, Stone GW, Mehran R, et al. Drug-coated balloons for the treatment of coronary artery disease: a review. JAMA Cardiol. (2025) 10:189&#x2013;98. doi: 10.1001/jamacardio.2024.4244, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2024.4244</ArticleId><ArticleId IdType="pubmed">39714903</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy IY, Gad MM, Elgendy AY, Mahmoud A, Mahmoud AN, Cuesta J, et al. Clinical and angiographic outcomes with drug-coated balloons for De novo coronary lesions: a Meta-analysis of randomized clinical trials. J Am Heart Assoc. (2020) 9:e016224. doi: 10.1161/JAHA.120.016224, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.016224</ArticleId><ArticleId IdType="pmc">PMC7660863</ArticleId><ArticleId IdType="pubmed">32410493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, He X, Ouyang F, Zhang Z, Shen G, Wu M, et al. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial. Lancet. (2024) 404:1040&#x2013;50. doi: 10.1016/S0140-6736(24)01594-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01594-0</ArticleId><ArticleId IdType="pubmed">39236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherasie FA, Ciomag Ianula R, Gherasie LM. Drug-coated balloon PCI in different plaque morphologies: a narrative review. Biomedicine. (2025) 13:1472. doi: 10.3390/biomedicines13061472, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines13061472</ArticleId><ArticleId IdType="pmc">PMC12190963</ArticleId><ArticleId IdType="pubmed">40564193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Cite space II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. (2005) 57:359&#x2013;77. doi: 10.1002/asi.20317</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/asi.20317</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. (2010) 84:523&#x2013;38. doi: 10.1007/s11192-009-0146-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-009-0146-3</ArticleId><ArticleId IdType="pmc">PMC2883932</ArticleId><ArticleId IdType="pubmed">20585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan-Montero Y, De-Moya-Aneg&#xf3;n F, Guerrero-Bote VP. Scimago graphica: a new tool for exploring and visually communicating data. Prof Inferm. (2022) 31:2. doi: 10.3145/epi.2022.sep.02</Citation><ArticleIdList><ArticleId IdType="doi">10.3145/epi.2022.sep.02</ArticleId></ArticleIdList></Reference><Reference><Citation>Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. (2017) 11:959&#x2013;75. doi: 10.1016/j.joi.2017.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2017.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos NS, Fagel ND, Amoroso G, Herrman JR, Patterson MS, Piers LH, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv. (2019) 12:1691&#x2013;9. doi: 10.1016/j.jcin.2019.04.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2019.04.016</ArticleId><ArticleId IdType="pubmed">31126887</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. (2013) 381:461&#x2013;7. doi: 10.1016/S0140-6736(12)61964-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61964-3</ArticleId><ArticleId IdType="pubmed">23206837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeger RV, Farah A, Ohlow MA, Mangner N, Mobius-Winkler S, Leibundgut G, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. (2018) 392:849&#x2013;56. doi: 10.1016/S0140-6736(18)31719-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31719-7</ArticleId><ArticleId IdType="pubmed">30170854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rissanen TT, Uskela S, Eranen J, Mantyla P, Olli A, Romppanen H, et al. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet. (2019) 394:230&#x2013;9. doi: 10.1016/S0140-6736(19)31126-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31126-2</ArticleId><ArticleId IdType="pubmed">31204115</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese B, Di Palma G, Guimaraes MG, Piraino D, Orrego PS, Buccheri D, et al. Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial. JACC Cardiovasc Interv. (2020) 13:2840&#x2013;9. doi: 10.1016/j.jcin.2020.08.035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2020.08.035</ArticleId><ArticleId IdType="pubmed">33248978</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann FJ, Sousa-Uva M. 'Ten commandments' for the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. (2019) 40:79&#x2013;80. doi: 10.1093/eurheartj/ehy855, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy855</ArticleId><ArticleId IdType="pubmed">30615155</ArticleId></ArticleIdList></Reference><Reference><Citation>Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. (2009) 119:2986&#x2013;94. doi: 10.1161/CIRCULATIONAHA.108.839282, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.839282</ArticleId><ArticleId IdType="pubmed">19487593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya FJ, Lefevre T, Chevalier B, Garot P, Hovasse T, Morice MC, et al. Contemporary approach to coronary bifurcation lesion treatment. JACC Cardiovasc Interv. (2016) 9:1861&#x2013;78. doi: 10.1016/j.jcin.2016.06.056, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2016.06.056</ArticleId><ArticleId IdType="pubmed">27659563</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrori ZMF, Frazzetto M, Mahmud SH, Alghwyeen W, Cortese B. Drug-coated balloons: recent evidence and upcoming novelties. J Cardiovasc Dev Dis. (2025) 12:194. doi: 10.3390/jcdd12050194, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd12050194</ArticleId><ArticleId IdType="pmc">PMC12112549</ArticleId><ArticleId IdType="pubmed">40422965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhogal S, Hill AP, Merdler I, Wermers JP, Ben-Dor I, Waksman R. Drug-coated balloons for coronary artery disease: An updated review with future perspectives. Cardiovasc Revasc Med. (2024) 69:79&#x2013;89. doi: 10.1016/j.carrev.2024.05.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2024.05.027</ArticleId><ArticleId IdType="pubmed">38845281</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee M. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. (2022) 79:e21&#x2013;e129. doi: 10.1016/j.jacc.2021.09.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.09.006</ArticleId><ArticleId IdType="pubmed">34895950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao XF, Ge Z, Kong XQ, Chen X, Han L, Qian XS, et al. Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE III trial. JACC Cardiovasc Interv. (2024) 17:1519&#x2013;28. doi: 10.1016/j.jcin.2024.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2024.04.014</ArticleId><ArticleId IdType="pubmed">38842991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (paclitaxel eluting PTCA balloon in coronary artery disease) trial. EuroIntervention. (2011) 7:K61&#x2013;5. doi: 10.4244/EIJV7SKA11</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV7SKA11</ArticleId><ArticleId IdType="pubmed">22027730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Qiao S, Su X, Chen Y, Jin Z, Chen H, et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial. JACC Cardiovasc Interv. (2018) 11:2381&#x2013;92. doi: 10.1016/j.jcin.2018.09.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.09.009</ArticleId><ArticleId IdType="pubmed">30522667</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Fu G, Tong Q, Liu B, Han X, Zhang J, et al. Biolimus-coated balloon in small-vessel coronary artery disease: the BIO-RISE CHINA study. JACC Cardiovasc Interv. (2022) 15:1219&#x2013;26. doi: 10.1016/j.jcin.2022.03.024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2022.03.024</ArticleId><ArticleId IdType="pubmed">35738744</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin ES, Jun EJ, Kim S, Kim B, Kim TH, Sohn CB, et al. Clinical impact of drug-coated balloon-based percutaneous coronary intervention in patients with multivessel coronary artery disease. JACC Cardiovasc Interv. (2023) 16:292&#x2013;9. doi: 10.1016/j.jcin.2022.10.049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2022.10.049</ArticleId><ArticleId IdType="pubmed">36609038</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacoppo D, Alfonso F, Xu B, Claessen B, Adriaenssens T, Jensen C, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. (2020) 75:2664&#x2013;78. doi: 10.1016/j.jacc.2020.04.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.006</ArticleId><ArticleId IdType="pubmed">32466881</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. (2012) 5:323&#x2013;30. doi: 10.1016/j.jcin.2012.01.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2012.01.008</ArticleId><ArticleId IdType="pubmed">22440499</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller B, Rissanen TT, Farah A, Ohlow MA, Mangner N, Wohrle J, et al. Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial. Circ Cardiovasc Interv. (2022) 15:e011569. doi: 10.1161/CIRCINTERVENTIONS.121.011569, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.121.011569</ArticleId><ArticleId IdType="pubmed">35411792</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller B, Ohlow MA, Ewen S, Kische S, Rudolph TK, Clever YP, et al. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial. EuroIntervention. (2020) 15:1527&#x2013;33. doi: 10.4244/EIJ-D-19-00723, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-19-00723</ArticleId><ArticleId IdType="pubmed">31659986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D, Scheller B, Schafer A, Klein G, Bohm M, Clever Y, et al. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. EuroIntervention. (2012) 8:450&#x2013;5. doi: 10.4244/EIJV8I4A71, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV8I4A71</ArticleId><ArticleId IdType="pubmed">22917728</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller B, Mangner N, Jeger RV, Afan S, Mahfoud F, Woitek FJ, et al. A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions. EuroIntervention. (2024) 20:e1322&#x2013;9. doi: 10.4244/EIJ-D-23-00868, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-23-00868</ArticleId><ArticleId IdType="pmc">PMC11522860</ArticleId><ArticleId IdType="pubmed">39492703</ArticleId></ArticleIdList></Reference><Reference><Citation>Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Reinhold J, Wickramarachchi U, et al. Assessment of paclitaxel drug-coated balloon only angioplasty in STEMI. JACC Cardiovasc Interv. (2023) 16:771&#x2013;9. doi: 10.1016/j.jcin.2023.01.380, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.01.380</ArticleId><ArticleId IdType="pubmed">37045498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese B, Testa G, Rivero F, Erriquez A, Alfonso F. Long-term outcome of drug-coated balloon vs drug-eluting stent for small coronary vessels: PICCOLETO-II 3-year follow-up. JACC Cardiovasc Interv. (2023) 16:1054&#x2013;61. doi: 10.1016/j.jcin.2023.02.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.02.011</ArticleId><ArticleId IdType="pubmed">37164603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninomiya K, Serruys PW, Colombo A, Reimers B, Basavarajaiah S, Sharif F, et al. A prospective randomized trial comparing Sirolimus-coated balloon with paclitaxel-coated balloon in De novo small vessels. JACC Cardiovasc Interv. (2023) 16:2884&#x2013;96. doi: 10.1016/j.jcin.2023.09.026, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.09.026</ArticleId><ArticleId IdType="pubmed">37877914</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedhom R, Hamed M, Elbadawi A, Mohsen A, Swamy P, Athar A, et al. Outcomes with limus- vs paclitaxel-coated balloons for percutaneous coronary intervention: meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. (2024) 17:1533&#x2013;43. doi: 10.1016/j.jcin.2024.04.042, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2024.04.042</ArticleId><ArticleId IdType="pubmed">38986653</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al. Sirolimus- vs paclitaxel-coated balloon for the treatment of coronary in-stent restenosis: the SIBLINT-ISR randomized trial. JACC Cardiovasc Interv. (2025) 18:963&#x2013;71. doi: 10.1016/j.jcin.2024.12.024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2024.12.024</ArticleId><ArticleId IdType="pubmed">39985511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for Femoropopliteal artery disease. N Engl J Med. (2015) 373:145&#x2013;53. doi: 10.1056/NEJMoa1406235, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406235</ArticleId><ArticleId IdType="pubmed">26106946</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, et al. Long-term clinical effectiveness of a drug-coated balloon for the treatment of Femoropopliteal lesions. Circ Cardiovasc Interv. (2019) 12:e007702. doi: 10.1161/CIRCINTERVENTIONS.118.007702, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.118.007702</ArticleId><ArticleId IdType="pmc">PMC6636795</ArticleId><ArticleId IdType="pubmed">31195825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. (2024) 45:3538&#x2013;700. doi: 10.1093/eurheartj/ehae179, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae179</ArticleId><ArticleId IdType="pubmed">39210722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjoumakaris SI, Roy JM, Amin-Hanjani S, Charbel FT, Dabus G, Fisher M, et al. ARISE II consensus on the Management of Intracranial Atherosclerotic Disease. Stroke. (2025) 56:1636&#x2013;41. doi: 10.1161/STROKEAHA.124.050336, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.124.050336</ArticleId><ArticleId IdType="pubmed">40408521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Deng Y, Zhang Y, Yang M, Sun D, Nguyen TN, et al. Balloon angioplasty vs medical Management for Intracranial Artery Stenosis: the BASIS randomized clinical trial. JAMA. (2024) 332:1059&#x2013;69. doi: 10.1001/jama.2024.12829, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.12829</ArticleId><ArticleId IdType="pmc">PMC11378071</ArticleId><ArticleId IdType="pubmed">39235816</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan TN, Derdeyn CP. Is balloon angioplasty the future for intracranial stenosis? JAMA. (2024) 332:1055&#x2013;6. doi: 10.1001/jama.2024.13547, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.13547</ArticleId><ArticleId IdType="pubmed">39235792</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y, Xiao D, Chen Y, Liu S. Therapeutic applications of drug coated balloons in symptomatic intracranial arterial stenosis: systematic review and quantitative meta-analysis. J Neurointerv Surg. (2025):jnis-2024-022878. doi: 10.1136/jnis-2024-022878, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnis-2024-022878</ArticleId><ArticleId IdType="pubmed">40044416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>